These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31532806)

  • 1. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    Braeye T; Bauchau V; Sturkenboom M; Emborg HD; García AL; Huerta C; Merino EM; Bollaerts K
    PLoS One; 2019; 14(9):e0222296. PubMed ID: 31532806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.
    Emborg HD; Kahlert J; Braeye T; Bauwens J; Bollaerts K; Danieli G; Duarte-Salles T; Glismann S; Huerta-Alvarez C; de Lusignan S; Martín-Merino E; McGee C; Correa A; Tramontan L; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B22-B30. PubMed ID: 31677953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Braeye T; Emborg HD; Llorente-García A; Huerta C; Martín-Merino E; Duarte-Salles T; Danieli G; Tramontan L; Weibel D; McGee C; Villa M; Gini R; Lehtinen M; Titievsky L; Sturkenboom M
    Vaccine; 2020 Apr; 38(16):3243-3254. PubMed ID: 32171573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
    Bollaerts K; de Smedt T; McGee C; Emborg HD; Villa M; Alexandridou M; Duarte-Salles T; Gini R; Bartolini C; de Lusignan S; Tin Tin Htar M; Titievsky L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B76-B83. PubMed ID: 31677951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
    Sturkenboom M; Braeye T; van der Aa L; Danieli G; Dodd C; Duarte-Salles T; Emborg HD; Gheorghe M; Kahlert J; Gini R; Huerta-Alvarez C; Martín-Merino E; McGee C; de Lusignan S; Picelli G; Roberto G; Tramontan L; Villa M; Weibel D; Titievsky L
    Vaccine; 2020 Dec; 38 Suppl 2():B8-B21. PubMed ID: 32061385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
    Bollaerts K; Ledent E; de Smedt T; Weibel D; Emborg HD; Danieli G; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Picelli G; Tramontan L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B65-B75. PubMed ID: 31677947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.
    Weibel D; Dodd C; Mahaux O; Haguinet F; De Smedt T; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Martín-Merino E; Huerta-Alvarez C; Berencsi K; Emborg HD; Bollaerts K; Bauchau V; Titievsky L; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B38-B46. PubMed ID: 31677946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.
    Dodd C; de Ridder M; Weibel D; Mahaux O; Haguinet F; de Smedt T; de Lusignan S; McGee C; Duarte-Salles T; Emborg HD; Huerta-Alvarez C; Martín-Merino E; Picelli G; Berencsi K; Danieli G; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B47-B55. PubMed ID: 32280043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
    Gini R; Dodd CN; Bollaerts K; Bartolini C; Roberto G; Huerta-Alvarez C; Martín-Merino E; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Becker BFH; Switzer C; Gandhi-Banga S; Bauwens J; van der Maas NAT; Spiteri G; Sdona E; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B56-B64. PubMed ID: 31677950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of Western Australia’s mandatory Midwives Notification System for routinely monitoring antenatal vaccine coverage.
    Regan AK; Effler PV; Thomson C; Mak DB
    Commun Dis Intell (2018); 2019 Jun; 43():. PubMed ID: 31203587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of vaccination coverage of adolescents aged 16-18 years with an innovative electronic immunization record system.
    Gault G; Fischer A; Nicand E; Burelle F; Burbaud A; Koeck JL
    Med Mal Infect; 2019 Feb; 49(1):38-46. PubMed ID: 30527973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
    Stein-Zamir C; Israeli A
    Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study.
    Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies.
    Fernández-Cano MI; Armadans Gil L; Campins Martí M
    Vaccine; 2015 May; 33(19):2213-2220. PubMed ID: 25825331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Childhood Vaccination Coverage of NIP Vaccines: Coverage Survey versus Zhejiang Provincial Immunization Information System.
    Hu Y; Chen Y
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28696387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016.
    Tippins A; Murthy N; Meghani M; Solsman A; Apaisam C; Basilius M; Eckert M; Judicpa P; Masunu Y; Pistotnik K; Pedro D; Sasamoto J; Underwood JM
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(20):579-584. PubMed ID: 29795077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.